GHK-Cu: Dosage, Protocol, and Research Guide
Copper peptide complex with tissue regeneration, anti-inflammatory, and cosmetic benefits
Mechanism
Naturally occurring copper complex that modulates gene expression, promotes collagen and elastin production, enhances angiogenesis, and provides antioxidant effects. Activates over 4000 human genes.
Protocol at a glance
| Starting dose | 1mg |
|---|---|
| Maintenance dose | 1-5mg |
| Maximum dose | 5mg |
| Frequency | Daily |
| Typical duration | 4-8 weeks |
| Route | Subcutaneous |
| Injection site | Abdomen or near injury |
| Timing | Any time of day |
Side effects
- Minimal reported
- Possible skin discoloration at injection site
Contraindications
- Wilson's disease
- Copper sensitivity
Protocol notes
- Promotes collagen and elastin synthesis
- Anti-inflammatory and antioxidant properties
- Improves skin elasticity and appearance
- Accelerates wound healing
- May improve hair growth
Frequently asked questions
Is GHK-Cu legal?
Research-grade peptides exist in a regulatory gray area. GHK-Cu is not FDA-approved for human use and is typically sold as a research chemical. Legal status varies by jurisdiction and intended use. Always verify local regulations before purchasing or using any research peptide. For research purposes only.
How should I cycle GHK-Cu?
GHK-Cu is typically used for a continuous duration of 4-8 weeks at a daily frequency. The peptide is administered starting at 1mg and maintained at 1-5mg daily via subcutaneous injection. Most protocols follow this consistent dosing pattern without cycling off, though individual protocols may vary based on research goals. Consult a licensed physician to determine the most appropriate approach for your specific circumstances.
Can GHK-Cu be stacked with other peptides?
Research on GHK-Cu stacking with other peptides remains limited. The available scientific literature does not provide specific guidance on combining GHK-Cu with other peptide compounds. Any stacking protocol should be carefully discussed with a licensed physician to ensure safety and to assess potential interactions.
What does GHK-Cu feel like when using it?
As a tissue regeneration and anti-inflammatory peptide, GHK-Cu does not typically produce immediate subjective sensations. Its effects are generally subtle and develop gradually over the 4-8 week duration of use, focusing on tissue-level changes such as improved collagen synthesis and accelerated wound healing rather than acute sensory experiences. Some users report gradual improvements in skin elasticity and appearance over time.
Will GHK-Cu show up in standard lab work?
Research on GHK-Cu laboratory markers remains limited. Standard blood work does not specifically test for GHK-Cu presence or levels. However, improved markers of collagen metabolism or general inflammatory status may potentially be observed during a GHK-Cu protocol. Any changes in lab results should be reviewed with a licensed physician to properly interpret findings.
What is the correct dosing protocol for GHK-Cu?
GHK-Cu dosing begins at a starting dose of 1mg and is maintained at 1-5mg daily via subcutaneous injection. The maximum dose is 5mg daily. The peptide is administered continuously for a duration of 4-8 weeks on a daily frequency schedule. Injection sites include the abdomen or near an injury site, and GHK-Cu can be administered at any time of day. A licensed physician should guide individualized dosing decisions.
What are the side effects from GHK-Cu?
Side effects from GHK-Cu are reported as minimal in the available literature. The primary potential concern is skin discoloration at the injection site. GHK-Cu should be avoided by individuals with Wilson's disease or copper sensitivity, as these are documented contraindications. For research purposes only — not FDA-approved for human use. Consult a licensed physician before use to determine if GHK-Cu is appropriate for your circumstances.
More Healing & Recovery peptides · All peptide guides · Free dose calculator
Educational reference only — not medical advice. Work with a qualified clinician.